Cargando…
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer’s disease, three-repeat tau in Pick’s disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degenerati...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418341/ https://www.ncbi.nlm.nih.gov/pubmed/33693528 http://dx.doi.org/10.1093/brain/awab091 |
_version_ | 1783748559282110464 |
---|---|
author | Tarutani, Airi Miyata, Haruka Nonaka, Takashi Hasegawa, Kazuko Yoshida, Mari Saito, Yuko Murayama, Shigeo Robinson, Andrew C Mann, David M A Tomita, Taisuke Hasegawa, Masato |
author_facet | Tarutani, Airi Miyata, Haruka Nonaka, Takashi Hasegawa, Kazuko Yoshida, Mari Saito, Yuko Murayama, Shigeo Robinson, Andrew C Mann, David M A Tomita, Taisuke Hasegawa, Masato |
author_sort | Tarutani, Airi |
collection | PubMed |
description | Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer’s disease, three-repeat tau in Pick’s disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) form amyloid-like fibrous structures that accumulate in neurons and/or glial cells. Amplification and cell-to-cell transmission of abnormal tau based on the prion hypothesis are believed to explain the onset and progression of tauopathies. Recent studies support not only the self-propagation of abnormal tau, but also the presence of conformationally distinct tau aggregates, namely tau strains. Cryogenic electron microscopy analyses of patient-derived tau filaments have revealed disease-specific ordered tau structures. However, it remains unclear whether the ultrastructural and biochemical properties of tau strains are inherited during the amplification of abnormal tau in the brain. In this study, we investigated template-dependent amplification of tau aggregates using a cellular model of seeded aggregation. Tau strains extracted from human tauopathies caused strain-dependent accumulation of insoluble filamentous tau in SH-SY5Y cells. The seeding activity towards full-length four-repeat tau substrate was highest in CBD-tau seeds, followed by PSP-tau and Alzheimer’s disease (AD)-tau seeds, while AD-tau seeds showed higher seeding activity than PiD-tau seeds towards three-repeat tau substrate. Abnormal tau amplified in cells inherited the ultrastructural and biochemical properties of the original seeds. These results strongly suggest that the structural differences of patient-derived tau strains underlie the diversity of tauopathies, and that seeded aggregation and filament formation mimicking the pathogenesis of sporadic tauopathy can be reproduced in cultured cells. Our results indicate that the disease-specific conformation of tau aggregates determines the tau isoform substrate that is recruited for templated amplification, and also influences the prion-like seeding activity. |
format | Online Article Text |
id | pubmed-8418341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-84183412021-09-09 Human tauopathy-derived tau strains determine the substrates recruited for templated amplification Tarutani, Airi Miyata, Haruka Nonaka, Takashi Hasegawa, Kazuko Yoshida, Mari Saito, Yuko Murayama, Shigeo Robinson, Andrew C Mann, David M A Tomita, Taisuke Hasegawa, Masato Brain Original Articles Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer’s disease, three-repeat tau in Pick’s disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) form amyloid-like fibrous structures that accumulate in neurons and/or glial cells. Amplification and cell-to-cell transmission of abnormal tau based on the prion hypothesis are believed to explain the onset and progression of tauopathies. Recent studies support not only the self-propagation of abnormal tau, but also the presence of conformationally distinct tau aggregates, namely tau strains. Cryogenic electron microscopy analyses of patient-derived tau filaments have revealed disease-specific ordered tau structures. However, it remains unclear whether the ultrastructural and biochemical properties of tau strains are inherited during the amplification of abnormal tau in the brain. In this study, we investigated template-dependent amplification of tau aggregates using a cellular model of seeded aggregation. Tau strains extracted from human tauopathies caused strain-dependent accumulation of insoluble filamentous tau in SH-SY5Y cells. The seeding activity towards full-length four-repeat tau substrate was highest in CBD-tau seeds, followed by PSP-tau and Alzheimer’s disease (AD)-tau seeds, while AD-tau seeds showed higher seeding activity than PiD-tau seeds towards three-repeat tau substrate. Abnormal tau amplified in cells inherited the ultrastructural and biochemical properties of the original seeds. These results strongly suggest that the structural differences of patient-derived tau strains underlie the diversity of tauopathies, and that seeded aggregation and filament formation mimicking the pathogenesis of sporadic tauopathy can be reproduced in cultured cells. Our results indicate that the disease-specific conformation of tau aggregates determines the tau isoform substrate that is recruited for templated amplification, and also influences the prion-like seeding activity. Oxford University Press 2021-03-09 /pmc/articles/PMC8418341/ /pubmed/33693528 http://dx.doi.org/10.1093/brain/awab091 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Tarutani, Airi Miyata, Haruka Nonaka, Takashi Hasegawa, Kazuko Yoshida, Mari Saito, Yuko Murayama, Shigeo Robinson, Andrew C Mann, David M A Tomita, Taisuke Hasegawa, Masato Human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
title | Human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
title_full | Human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
title_fullStr | Human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
title_full_unstemmed | Human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
title_short | Human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
title_sort | human tauopathy-derived tau strains determine the substrates recruited for templated amplification |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418341/ https://www.ncbi.nlm.nih.gov/pubmed/33693528 http://dx.doi.org/10.1093/brain/awab091 |
work_keys_str_mv | AT tarutaniairi humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT miyataharuka humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT nonakatakashi humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT hasegawakazuko humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT yoshidamari humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT saitoyuko humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT murayamashigeo humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT robinsonandrewc humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT manndavidma humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT tomitataisuke humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification AT hasegawamasato humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification |